Price to Earnings of Takara Bio

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Price to Earnings analysis of Takara Bio


 Price 2,417.00  JPY
 Earnings per share 30.36  JPY
 Capitalization (mn) 110,597  JPY
 Net income (mn) 3,643  JPY
 P/E ratio 79.60
 Takara Bio dividend
 Takara Bio Price to book Value
 Takara Bio Price to Cash-Flow
 Takara Bio Return on Equity

Takara Bio is a Health Care industry firm, which concentrates their activity in the Pharmaceuticals and Biotechnology sector. Takara Bio headquarters are in Japan, where the firm is listed.

At the time of this analysis, Takara Bio stocks were trading at a price of 2,417.00 JPY after hiking a 8.30% last month.

According to the chart displayed below, Takara Bio Price to Earnings Ratio is 79.60, bigger than the amount offered by both firms from Japan and fromPharmaceuticals and Biotechnology sector. This high P/E might be a sign of a overvalued company, but also a healthy sign because the market expects growing earnings in the future.Therefore, it is necessary to study Takara Bio financial situation to reach a conclussion.

Finally, you could compare Takara Bio P/E with other Pharmaceuticals and Biotechnology companies or firms from Japan.

Takara Bio price to earnings

Next companies

Takara Holdings. Japan. Consumer Goods.

Takashimaya. Japan. Consumer Services.

Take-Two Interactive Software. USA. Consumer Goods.

Takeda Pharm. Japan. Health Care.

TAL Education Group. China. Consumer Services.

Talaat Moustafa Grou. Egypt. Financials.

Previous companies

Taiyo Yuden. Japan. Industrials.

Taiyo Nippon Sanso. Japan. Basic Materials.

Taiwan Semiconductor. Taiwan. Technology.

Taiwan Secom. Taiwan. Industrials.

Taiwan Mobile. Taiwan. Telecommunications.

Taiwan High Speed Rail. Taiwan. Industrials.

All rights reserved

 information advertisement legal

Dividends Ranking | Price to BookValue | Price to Cash-Flow | Price to Earnings | Return on Equity

Part of Enciclopedia Financiera Group

Disclaimer: Information on this site is only for informational purposes. Always consult a professional advisor before investing.